Pura Vida Investments’s Globus Medical GMED Stock Holding History

Pura Vida Investments’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-80,000	Closed	-$3.47M	–	112
2019 Q1	$3.95M	Buy	+80,000	New	+$3.62M	0.56%	53
2018 Q4	–	Sell	-57,500	Closed	-$3.26M	–	90
2018 Q3	$3.26M	Sell	57,500 -10,000	-15%	-$526K	0.69%	46
2018 Q2	$3.41M	Sell	67,500 -67,500	-50%	-$3.52M	1.37%	20
2018 Q1	$6.73M	Sell	135,000 -47,500	-26%	-$2.23M	3.97%	4
2017 Q4	$7.5M	Buy	182,500 +53,426	+41%	+$1.87M	3.14%	6
2017 Q3	$3.84M	Sell	129,074 -70,926	-35%	-$2.17M	1.12%	35
2017 Q2	$6.63M	Sell	200,000 -85,646	-30%	-$2.69M	2.63%	13
2017 Q1	$8.46M	Buy	285,646 +85,646	+43%	+$2.34M	2.5%	8
2016 Q4	$4.96M	Buy	+200,000	New	+$4.54M	1.82%	20

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Pura Vida Investments's GMED Position: Q2 2019 in Review

Pura Vida Investments sold out of Globus Medical (GMED) in Q2 2019, closing a stake of 80,000 shares — an estimated $3.47M sold.

Pura Vida Investments first reported a position in GMED in Q4 2016 and held it in 9 quarters. The position peaked at $8.46M in Q1 2017. 259 funds tracked by Wall St. Rank hold GMED as of Q2 2019.

Pura Vida Investments reported no remaining Globus Medical position as of Q2 2019 after selling out during the quarter.
Pura Vida Investments sold 80,000 Globus Medical shares in Q2 2019, an estimated $3.47M.
Pura Vida Investments first reported a position in Globus Medical in Q4 2016 and held it in 9 quarters.
Pura Vida Investments's Globus Medical position peaked at $8.46M in Q1 2017.
259 funds tracked by Wall St. Rank held Globus Medical as of Q2 2019.

Based on Pura Vida Investments's 13F filing for Q2 2019, filed 14 Aug 2019.